2-(Methylsulfanyl)-4-(naphthalen-2-yloxy)thieno[3,2-d]pyrimidine

Catalog No. :
ACHJQV513
CAS No. :
339018-89-2
Molecular Formula :
C17H12N2OS2
Molecular Weight :
324.43

IUPAC Name:2-(methylthio)-4-(naphthalen-2-yloxy)thieno[3,2-d]pyrimidine

2-(Methylsulfanyl)-4-(naphthalen-2-yloxy)thieno[3,2-d]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$325.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Methylsulfanyl)-4-(naphthalen-2-yloxy)thieno[3,2-d]pyrimidine
IUPAC Name2-(methylthio)-4-(naphthalen-2-yloxy)thieno[3,2-d]pyrimidine
MDL No.MFCD01444027
Molecular FormulaC17H12N2OS2
Molecular Weight324.43
SMILESCSC1=NC(OC2=CC=C3C=CC=CC3=C2)=C4C(C=CS4)=N1
InChI KeyRQHGHXYLEDARBP-UHFFFAOYSA-N
Synonym2-(METHYLSULFANYL)-4-(2-NAPHTHYLOXY)THIENO[3,2-D]PYRIMIDINE;2-(METHYLSULFANYL)THIENO[3,2-D]PYRIMIDIN-4-YL 2-NAPHTHYL ETHER;2-(methylsulfanyl)-4-(naphthalen-2-yloxy)thieno[3,2-d]pyrimidine;Thieno[3,2-d]pyrimidine, 2-(methylthio)-4-(2-naphthalenyloxy)-
CAS No.339018-89-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACHJQV513 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHJQV513 route product structure diagram
    ACHJQV513339018-89-2
Inquiry

2. ACHJQV513 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHJQV513 route product structure diagram
    ACHJQV513339018-89-2
Inquiry

Comments (0)